You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-beta

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Recruiting
  • Breast Cancer
  • +2 more
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 12, 2022

    Uterine Cancer Trial in Philadelphia (18F-Fluoroestradiol)

    Not yet recruiting
    • Uterine Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 21, 2023

    Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

    Not yet recruiting
    • Low Grade Serous Ovarian Carcinoma
    • Adult Type Granulosa Cell Tumor
    • Gent, Oost-Vlaanderen, Belgium
    • +2 more
    May 12, 2023

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

    Not yet recruiting
    • Breast Cancer
    • Brain Metastases
    • Brain Imaging with 18F-FES
    • New York, New York
      New York-Presbyterian/Weill Cornell Medical Center
    Oct 2, 2023

    Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

    Not yet recruiting
    • Adenocarcinoma Esophagus
    • +3 more
    • (no location specified)
    Sep 13, 2023

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • ARV-471 (PF-07850327)
    • +2 more
    • Orange City, Florida
      Mid Florida Hematology and Oncology Center
    Jun 8, 2023

    Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Frozen Embryo Transfer, Infertility, Female Trial in Udaipur (17-beta Estradiol gel 0.06% w/w(ESTOGEL.Intas pharma), Estradiol

    Not yet recruiting
    • Frozen Embryo Transfer
    • Infertility, Female
    • 17-beta Estradiol gel 0.06% w/w(ESTOGEL.Intas pharma)
    • Estradiol Hemihydrate(Estrabet Tablet, abbott pharma)
    • Udaipur, Rajasthan, India
      Indira IVF Hospital Private Limited
    Apr 4, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

    Recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Breast Cancer
    • Houston, Texas
      Houston Methodist Cancer Center
    Nov 18, 2022

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Metastatic Breast Cancer Trial (Elacestrant)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2022

    Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • Low Grade Serous Adenocarcinoma of Ovary
    • Letrozole tablets
    • carboplatin AUC 5 and paclitaxel 175 mg/m2
    • Brescia, BS, Italy
    • +1 more
    Oct 26, 2022

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

    Not yet recruiting
    • Hematologic Malignancy
    • +21 more
    • (no location specified)
    Feb 9, 2023

    Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • AND019 PO QD
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 19, 2022

    Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])

    Recruiting
    • Overactive Bladder Syndrome
    • Vaginal estrogen
    • Mirabegron 50 MG [Myrbetriq]
    • Bethesda, Maryland
      Walter Reed National Military Medical Center
    Nov 3, 2022

    Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant (SAR439859)
    • Chuo-Ku, Japan
    • +2 more
    Nov 16, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Prognostic Stage IV Breast Cancer AJCC v8
    • Pembrolizumab
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2023

    Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

    Completed
    • Advanced ER+, HER2-Negative Breast Cancer
    • Waltham, Massachusetts
      Radius Pharmaceuticals, Inc.
    Aug 16, 2022